AMANDA HOUSE: Open Payments
NPI 1013303221 · SPRINGFIELD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,023 in 70 payments from 16 companies in 2025. Trend: 2023 $970 · 2024 $914 · 2025 $1,023
Food & beverage: $1,023
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 33 | $220 |
| Amgen Inc. | 12 | $177 |
| AstraZeneca Pharmaceuticals LP | 3 | $161 |
| Novo Nordisk Inc | 6 | $122 |
| E.R. Squibb & Sons, L.L.C. | 3 | $58 |
| Boston Scientific Corporation | 2 | $50 |
| Abbott Laboratories | 1 | $39 |
| Alnylam Pharmaceuticals Inc. | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Recor Medical Inc | 1 | $25 |
Products named: LEQVIO, REPATHA, FARXIGA, Wegovy, WATCHMAN Access System, ELIQUIS, JOT DX, AMVUTTRA.
Industry payments across IL — which companies pay providers there.
